EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN PATIENTS WITH DECOMPENSATED HEPATITIS B CIRRHOSIS

被引：0
|
作者：
Deng, You [1 ]
Cui, Weili [2 ]
Yue, Jin [3 ]
Li, Jinlong [4 ]
Zhang, Shuqian [1 ]
Wang, Qi [1 ]
Zhao, Hong [1 ]
Chen, Wenya [1 ]
Li, Jiashuo [1 ]
Li, Mengqi [1 ]
Lai, Xiaohuan [4 ]
Guo, Xiaoqing [3 ]
Qiao, Bing [2 ]
Xie, Wen [1 ]
机构：
[1] Capital Med Univ, Beijing Ditan Hosp, Beijing, Peoples R China
[2] Qingdao Sixth Peoples Hosp, Qingdao, Peoples R China
[3] Third Peoples Hosp Taiyuan, Taiyuan, Peoples R China
[4] Ganzhou Fifth Peoples Hosp, Ganzhou, Peoples R China
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2241
引用
收藏
页码：S1696 / S1697
页数：2
相关论文
共 50 条
  • [31] EFFECTIVENESS AND SAFETY OF TENOFOVIR ALAFENAMIDE IN CHRONIC HEPATITIS B PATIENTS WITH SUBOPTIMAL RESPONSE TO ANTIVIRAL THERAPY
    Xie, Wen
    Cao, Lihua
    Dang, Shuangsuo
    Zhu, Liying
    Yang, Dongliang
    Zhu, Yueyong
    Dou, Xiaoguang
    Gao, Zhiliang
    Chen, Binbin
    Zhang, Xinxin
    Wang, Yuming
    Liu, Yan
    Zhang, Ting
    Ye, Tingdan
    Mi, Ke
    Pan, Calvin
    HEPATOLOGY, 2024, 80 : S199 - S200
  • [32] One-year efficacy of tenofovir alafenamide in patients with chronic hepatitis B An observational study
    Chen, Yi-Cheng
    Hsu, Chao-Wei
    Chien, Rong-Nan
    Tai, Dar-In
    MEDICINE, 2022, 101 (25) : E29269
  • [33] Tenofovir Alafenamide: A Review in Chronic Hepatitis B
    Lesley J. Scott
    Henry L. Y. Chan
    Drugs, 2017, 77 : 1017 - 1028
  • [34] Tenofovir alafenamide for hepatitis B: evolution or revolution?
    Brouwer, Willem P.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2016, 1 (03): : 174 - 175
  • [35] Can We Trust Safety of Tenofovir Disoproxil in Patients with Decompensated Cirrhosis?
    Oh, Hyunwoo
    Jun, Dae Won
    GUT AND LIVER, 2017, 11 (06) : 743 - 744
  • [36] Effectiveness and safety with tenofovir alafenamide (TAF) for hepatitis B in US clinical practice
    Curry, Michael
    Bae, Ho
    Dieterich, Douglas
    Ankoma-Sey, Victor
    Reddy, Rajender
    Pan, Calvin
    Hann, Hie-Won
    Tong, Myron
    Kim, W. Ray
    Kwo, Paul
    Frazier, Lynn
    Milligan, Scott
    Spitz, Keith
    Afdhal, Nezam
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E462 - E462
  • [37] SAFETY AND EFFICACY AT 1 YEAR IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B (CHB) RECEIVING TENOFOVIR ALAFENAMIDE (TAF)
    Schwarz, Kathleen B.
    Bezerra, Jorge A.
    Choe, Byung-Ho
    Lin, Chuan-Hao
    Abramov, Frida
    Nguyen, Anh-Hoa
    Liu, Yang
    Flaherty, John F.
    Pacurar, Daniela
    Kim, Kyung Mo
    Khaertynova, Ilsiyar
    Shalimar
    Wu, Jia-Feng
    Tandon, Manish
    Rosenthal, Philip
    Morozov, Viacheslav
    Sokal, Etienne
    Chang, Mei-Hwei
    HEPATOLOGY, 2022, 76 : S300 - S301
  • [38] Tenofovir Alafenamide: A Review in Chronic Hepatitis B
    Scott, Lesley J.
    Chan, Henry L. Y.
    DRUGS, 2017, 77 (09) : 1017 - 1028
  • [39] Efficacy of entecavir in naive patients with chronic hepatitis B and decompensated liver cirrhosis
    Kao, J-T
    Peng, C-Y
    Lai, H-C
    Chuang, P-H
    Su, W-P
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A202 - A202
  • [40] Clinical Efficacy and Safety of Long-Term Treatment of Tenofovir Alafenamide vs Tenofovir Disoproxil Fumarate for Chronic Hepatitis B in Vietnam
    Nguyen, Thao Huynh Phuong
    Bui, Quynh Thi Huong
    Vo, Thong Duy
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2024, 15 (10)
12345